Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study
Titel:
Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study
Auteur:
Clemons, Mark J. Cochrane, Brandy Pond, Gregory R. Califaretti, Nadia Chia, Stephen K. L. Dent, Rebecca Alexandra Song, Xinni Robidoux, Andre Parpia, Sameer Warr, David Rayson, Daniel Pritchard, Kathleen I. Levine, Mark N.